NL-OMON38088
Completed
Phase 4
DIAbetes-PREvention Trial - DiaPreT
Isala Klinieken0 sites78 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- pre-diabetici
- Sponsor
- Isala Klinieken
- Enrollment
- 78
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria ;• • Patients admitted with coronairy artery disease (PCI or CABG in stable CAD, or post STEMI and post non\-STEMI) (inclusion within 2 month after admission) ;• Age \>\= 18 years ;• Elevated HbA1c levels (HbA1c \> 5\.8% or \> 40 mmol/mol) on admission ;• Access to a computer with internet connection;• Written informed consent
Exclusion Criteria
- •Exclusion criteria ;• Known diabetics, with or without anti\-diabetic medication ;• Contra\-indications for Metformine use as stated in the medication registration;• Life Expectancy \<1 yr ;• Physical limitations/restrictions for participation in exercise programme or exercise testing ;• Fasting plasma glucose \>\= 7\.0 mmol/l or HbA1c \>\= 53
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Diabetes-Prevention TrialPatients who are candidates for cardiac rehabilitation after documented coronairy artery disease (PCI or CABG in stable CAD, or post STEMI and post non-STEMI), who have pre-diabetesMedDRA version: 14.1Level: LLTClassification code 10064346Term: STEMISystem Organ Class: 100000004849MedDRA version: 14.1Level: LLTClassification code 10036482Term: Pre-diabeticSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2011-002469-39-NLIsala Klinieken
Suspended
Not Applicable
DIAbetes-PREvention Trial.Coronary artery disease (CAD): PCI or CABG in stable CAD, or post STEMI and post non-STEMI, Cardiac rehabilitation , Diabetes MellitusNL-OMON21355Isala Klinieken, te ZwolleMaatschap Cardiologie, Interne en sportgeneeskunde, Isala Klinieken.78
Not yet recruiting
Phase 4
Prevention of onset of diabetes with life style modifications prescribed exercises prescribed diet yoga and drug therapy with metformin if neededHealth Condition 1: null- Type 2 diabetes mellitusCTRI/2011/09/002009Department of Science and Technology Government of India200
Completed
Not Applicable
Early Diabetes Intervention TrialImpaired glucose toleranceNutritional, Metabolic, EndocrineDiabetesISRCTN96631607Bayer plc and Merck-Lipha (UK)631
Not yet recruiting
Phase 2
Pilot Clinical Trial for Treatment of Diabetic Foot Ulcers with Dietary Nano-formulated Phytochemicalsdiabetic foot ulcersMetabolic and Endocrine - DiabetesACTRN12610000565044CamMedica, Ltd.35